@article{1b0ffa4850aa4c85946f5e626a643189,
title = "A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?",
author = "{GOIM (Gruppo Oncologico dell{\textquoteright}Italia Meridionale)} and Mariangela Ciccarese and Laura Orlando and Palma Fedele and Paola Schiavone and Evaristo Maiello and Giuseppina Cilenti and Michele Aieta and Giovanni Bozza and Rosachiara Forcignan{\`o} and Antonio Febbraro and Roberto Bordonaro and Sante Romito and Antonio Rinaldi and Nicolo' Borsellino and Ferdinando Riccardi and Salvatore Pisconti and Vito Lorusso and Giuseppe Colucci and Giammarco Surico and Valeria Saracino and Saverio Cinieri",
note = "Funding Information: We thank Michele di Candia MD for help in the preparation of the manuscript. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
year = "2020",
month = sep,
day = "1",
doi = "10.1111/tbj.13856",
language = "English",
volume = "26",
pages = "1857--1859",
journal = "Breast Journal",
issn = "1075-122X",
publisher = "Wiley-Blackwell",
number = "9",
}